Anna M. Piet
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-Term Outcomes of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Prostate Cancer: Results From a Real-World Large Patient Cohort.
Journal: International journal of radiation oncology, biology, physics
Published: July 22, 2025
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 23, 2021
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Journal: International journal of radiation oncology, biology, physics
Published: March 27, 2019
Effect of Neoadjuvant Chemoradiotherapy on Health-Related Quality of Life in Esophageal or Junctional Cancer: Results From the Randomized CROSS Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 22, 2017
PET-Guided Stereotactic Irradiation of Prostate Cancer Lymph Node Metastases.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 20, 2016
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Journal: The Lancet. Oncology
Published: April 29, 2015
Lymph node retrieval during esophagectomy with and without neoadjuvant chemoradiotherapy: prognostic and therapeutic impact on survival.
Journal: Annals of surgery
Published: November 08, 2014
Preoperative chemoradiotherapy for esophageal or junctional cancer.
Journal: The New England journal of medicine
Published: June 01, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026